“…Inflammatory myofibroblastic tumor is an entity with distinctive histopathologic characteristics but interchangeably designated with a vast array of terms (eg, inflammatory pseudotumor, plasma cell granuloma, inflammatory fibrosarcoma, fibrous histiocytoma, inflammatory fibroid polyp, inflammatory myofibrohistiocytic proliferation, inflammatory myofibroblastic proliferation, omental mesenteric myxoid hamartoma, xanthoma, fibroxanthoma, and xanthogranuloma) [8,9]. Additional features such as wide clinical presentation, variable course, scarce series reports, and absence of controlled studies have not allowed a definitive etiopathogenesis, an appropriate therapeutic approach, and an accurate prognosis to be established [2,[7][8][9].…”